*These organizations are independent nonprofit organizations. Their inclusion here does not indicate or imply endorsement of TEPMETKO or EMD Serono, Inc.
In addition, EMD Serono, Inc. has no control over and takes no responsibility for the content of these websites.
What Warnings should I know about TEPMETKO?
TEPMETKO may cause severe or life-threatening swelling (inflammation) of the lungs during treatment that can lead to death. Tell your healthcare provider right away if you develop any new or worsening symptoms of lung problems, including: trouble breathing; shortness of breath; cough; or fever.
TEPMETKO may cause abnormal liver blood test results. One patient died from liver failure. Your healthcare provider will do blood tests to check your liver function before you start treatment and during treatment with TEPMETKO. Tell your healthcare provider right away if you develop any signs and symptoms of liver problems, including: your skin or the white part of your eyes turns yellow; dark or “tea colored” urine; light-colored stools (bowel movements); confusion; tiredness; loss of appetite for several days or longer; nausea and vomiting; pain, aching, or tenderness on the right side of your stomach-area (abdomen); weakness; or swelling in your stomach-area.
TEPMETKO may cause increases in your blood amylase and lipase levels that may indicate a problem with your pancreas. Your healthcare provider will do blood tests to check your pancreatic function before you start treatment and during treatment with TEPMETKO. Tell your healthcare provider right away if you develop upper stomach (abdominal) pain, weight loss, nausea, or vomiting.
TEPMETKO can cause harm to an unborn baby in pregnant women.
Females who are able to become pregnant:
Males with female partners who are able to become pregnant should use effective birth control during treatment with TEPMETKO and for 1 week after the last dose of TEPMETKO.
What should I tell my health care provider?
Tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the side effects of TEPMETKO?
The most common side effects of TEPMETKO include: swelling in your face or other parts of your body; nausea; tiredness; diarrhea; muscle and joint pain; diarrhea; shortness of breath; loss of appetite; rash; and changes in certain blood tests. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with TEPMETKO if you develop serious side effects during treatment. These are not all of the possible side effects of TEPMETKO. Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
What is TEPMETKO used for?
TEPMETKO is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that:
It is not known if TEPMETKO is safe and effective in children.
Please see full Prescribing Information and Patient Information.
What Warnings should I know about TEPMETKO?
TEPMETKO may cause severe or life-threatening swelling (inflammation) of the lungs during treatment that can lead to death. Tell your healthcare provider right away if you develop any new or worsening symptoms of lung problems, including: trouble breathing; shortness of breath; cough; or fever.
TEPMETKO may cause abnormal liver blood test results. One patient died from liver failure. Your healthcare provider will do blood tests to check your liver function before you start treatment and during treatment with TEPMETKO. Tell your healthcare provider right away if you develop any signs and symptoms of liver problems, including: your skin or the white part of your eyes turns yellow; dark or “tea colored” urine; light-colored stools (bowel movements); confusion; tiredness; loss of appetite for several days or longer; nausea and vomiting; pain, aching, or tenderness on the right side of your stomach-area (abdomen); weakness; or swelling in your stomach-area.
TEPMETKO may cause increases in your blood amylase and lipase levels that may indicate a problem with your pancreas. Your healthcare provider will do blood tests to check your pancreatic function before you start treatment and during treatment with TEPMETKO. Tell your healthcare provider right away if you develop upper stomach (abdominal) pain, weight loss, nausea, or vomiting.
TEPMETKO can cause harm to an unborn baby in pregnant women.
Females who are able to become pregnant:
Males with female partners who are able to become pregnant should use effective birth control during treatment with TEPMETKO and for 1 week after the last dose of TEPMETKO.
What should I tell my health care provider?
Tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the side effects of TEPMETKO?
The most common side effects of TEPMETKO include: swelling in your face or other parts of your body; nausea; tiredness; diarrhea; muscle and joint pain; diarrhea; shortness of breath; loss of appetite; rash; and changes in certain blood tests. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with TEPMETKO if you develop serious side effects during treatment. These are not all of the possible side effects of TEPMETKO. Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
What is TEPMETKO used for?
TEPMETKO is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that:
It is not known if TEPMETKO is safe and effective in children.
Please see full Prescribing Information and Patient Information.
US-TEP-00871
Last update 07/2024
© 2024 Merck KGaA, Darmstadt, Germany or affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada.
TEPMETKO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
Use and access of this site are subject to the terms and conditions set out in our Legal Statement and Privacy Policy.
This site contains information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy. This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada.
